Inactive Instrument
Guided Therapeutics Inc Stock OTC Bulletin Board
Stocks
US40171F1057
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| Market Cap | 24.13M 20.67M 19.34M 17.68M 33.38M 2.3B 33.69M 228M 88.87M 1.16B 90.61M 88.64M 3.84B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 27.01M 23.13M 21.64M 19.79M 37.36M 2.58B 37.71M 255M 99.46M 1.3B 101M 99.2M 4.3B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 06/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 02/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 01/12/2016 |
John Imhoff
BRD | Director/Board Member | 76 | 10/04/2006 |
Michael James
CHM | Chairman | 67 | 01/10/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.09% | +7.28% | +25.63% | +16.75% | 232B | ||
| +0.40% | +6.58% | +1.97% | -14.82% | 151B | ||
| -0.46% | -4.74% | -21.91% | +30.18% | 132B | ||
| +1.73% | -3.05% | -53.04% | -1.13% | 71.03B | ||
| -1.71% | +1.79% | -17.26% | -13.17% | 52.46B | ||
| +0.41% | +0.07% | +11.05% | +21.14% | 52.16B | ||
| +0.87% | +4.26% | +27.25% | +29.53% | 43.33B | ||
| +0.90% | +1.64% | +37.15% | +52.83% | 40.36B | ||
| -0.38% | +2.13% | -1.74% | +8.01% | 33.51B | ||
| Average | -0.00% | +1.82% | +1.01% | +14.37% | 89.84B | |
| Weighted average by Cap. | -0.03% | +2.78% | +2.34% | +11.93% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6K 5.61K 5.13K 9.68K 668K 9.77K 66.16K 25.78K 336K 26.28K 25.71K 1.11M | 767K 657K 615K 562K 1.06M 73.17M 1.07M 7.25M 2.82M 36.87M 2.88M 2.82M 122M |
| Net income | -2.42M -2.07M -1.94M -1.77M -3.34M -231M -3.37M -22.84M -8.9M -116M -9.07M -8.88M -385M | -3.2M -2.74M -2.56M -2.34M -4.42M -305M -4.46M -30.21M -11.77M -154M -12M -11.74M -509M |
| Net Debt | 1.77M 1.52M 1.42M 1.3M 2.45M 169M 2.47M 16.74M 6.52M 85.12M 6.65M 6.5M 282M | 2.88M 2.46M 2.3M 2.11M 3.98M 274M 4.01M 27.18M 10.59M 138M 10.8M 10.56M 458M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















